<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Allogeneic bone marrow transplantation (BMT) is the treatment of choice in young patients (pts) with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) who have an HLA identical sibling donor </plain></SENT>
<SENT sid="1" pm="."><plain>Late graft rejection to following allogeneic BMT for SAA is a significant clinical problem and is associated with a high risk of mortality </plain></SENT>
<SENT sid="2" pm="."><plain>The optimal treatment strategy for patients with late graft rejection after first BMT is still an open question </plain></SENT>
<SENT sid="3" pm="."><plain>We report 12-year-old patient with acquired SAA who underwent BMT from his HLA identical sister </plain></SENT>
<SENT sid="4" pm="."><plain>BMT was first-line treatment within 3 months of diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>Preparative therapy was <z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> (Cy) 200 mg/kg body mass (BM) during 4 days </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">Graft versus host disease</z:e> (GVHD) was prevented with <z:chebi fb="0" ids="44185">Methotrexate</z:chebi> (MTX), <z:chebi fb="0" ids="6888">Methylprednisolone</z:chebi> (MPDN) and <z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> (CsA) </plain></SENT>
<SENT sid="7" pm="."><plain>After 17 months, during which patient was with <z:mpath ids='MPATH_458'>normal</z:mpath> blood counts and full donor chimaerism, graft rejection occurred </plain></SENT>
<SENT sid="8" pm="."><plain>The patient was re-engrafted from the same donor after conditioning with Cy 200 mg/kg BM plus horse antithymocyte globulin (ATG)--2 vials (รก 25 mg)/10 kg BM over 4 days </plain></SENT>
<SENT sid="9" pm="."><plain>Before the collection, donor's bone marrow was activated with low dose rhGM-CSF (3 micrograms/kg one day) </plain></SENT>
<SENT sid="10" pm="."><plain>Following a secondary BMT engraftment has sustained </plain></SENT>
<SENT sid="11" pm="."><plain>The patient is alive with full donor chimaerism 26 months from secondary transplantation, without <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD </plain></SENT>
</text></document>